Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bridler

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Acta Psychiatrica Scandinavica|July 14, 2006
Brain imaging in psychiatry - a study of 435 psychiatric in-patients at a university clinicC Mueller, M Rufer, H Moergeli, et al.
Der Nervenarzt|June 2, 2009
[Community-based crisis home programme. Cost-efficient alternative to psychiatric hospitalization]K Lötscher, H H Stassen, D Hell, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 19, 2003
Ethnicity-independent genetic basis of functional psychoses: a genotype-to-phenotype approachH H Stassen, R Bridler, D Hell, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 11, 2024
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and ChinaH H Stassen, S Bachmann, R Bridler, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 23, 2020
Inflammatory processes linked to major depression and schizophrenic disorders and the effects of polypharmacy in psychiatry: evidence from a longitudinal study of 279 patients under therapyH H Stassen, S Bachmann, R Bridler, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 25, 2021
Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophreniaH H Stassen, S Bachmann, R Bridler, et al.
American Journal of Medical Genetics|July 14, 2000
Schizophrenia and smoking: evidence for a common neurobiological basis?H H Stassen, R Bridler, S Hägele, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 28, 2025
Genetic predisposition to unwanted side effects under antidepressants and antipsychotics: a molecular-genetic study of 902 patients over 6 weeksHans H Stassen, S Bachmann, R Bridler, et al.
Psychiatry Research|January 15, 2024
Analysis of genetic diversity in patients with major psychiatric disorders versus healthy controls: A molecular-genetic study of 1698 subjects genotyped for 100 candidate genes (549 SNPs)H H Stassen, S Bachmann, R Bridler, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 8, 2024
Genetic determinants of antidepressant and antipsychotic drug responseHans H Stassen, S Bachmann, R Bridler, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Acta Psychiatrica Scandinavica|July 14, 2006
Brain imaging in psychiatry - a study of 435 psychiatric in-patients at a university clinicC Mueller, M Rufer, H Moergeli, et al.
Der Nervenarzt|June 2, 2009
[Community-based crisis home programme. Cost-efficient alternative to psychiatric hospitalization]K Lötscher, H H Stassen, D Hell, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 19, 2003
Ethnicity-independent genetic basis of functional psychoses: a genotype-to-phenotype approachH H Stassen, R Bridler, D Hell, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 11, 2024
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and ChinaH H Stassen, S Bachmann, R Bridler, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 23, 2020
Inflammatory processes linked to major depression and schizophrenic disorders and the effects of polypharmacy in psychiatry: evidence from a longitudinal study of 279 patients under therapyH H Stassen, S Bachmann, R Bridler, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 25, 2021
Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophreniaH H Stassen, S Bachmann, R Bridler, et al.
American Journal of Medical Genetics|July 14, 2000
Schizophrenia and smoking: evidence for a common neurobiological basis?H H Stassen, R Bridler, S Hägele, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 28, 2025
Genetic predisposition to unwanted side effects under antidepressants and antipsychotics: a molecular-genetic study of 902 patients over 6 weeksHans H Stassen, S Bachmann, R Bridler, et al.
Psychiatry Research|January 15, 2024
Analysis of genetic diversity in patients with major psychiatric disorders versus healthy controls: A molecular-genetic study of 1698 subjects genotyped for 100 candidate genes (549 SNPs)H H Stassen, S Bachmann, R Bridler, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 8, 2024
Genetic determinants of antidepressant and antipsychotic drug responseHans H Stassen, S Bachmann, R Bridler, et al.
Pageof 3